BAIAP1 (MAGI1)Antibody (C-term) Blocking peptide

The synthetic peptide sequence used to generate the antibody was selected from the C-term region of human BAIAP1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform b; Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1; membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1; membrane associated guanylate kinase, WW and PDZ domain containing 1; Atrophin-1-interacting protein 3; AIP-3; BAI1-associated protein 1; BAP-1; Membrane-associated guanylate kinase inverted 1; MAGI-1; Trinucleotide repeat-containing gene 19 protein; WW domain-containing protein 3; WWP3]